Although intussusception is a well recognised surgical condition in infants globally, accurate data on the epidemiology and clinical presentation is limited, particularly in developing countries . What data that is available suggests that there may be variability in the baseline incidence of intussusception between regions  and , making data on the incidence of intussusception obtained only from post-marketing surveillance activities extremely difficult to interpret. Wnt tumor One of the most common methods to evaluate the impact of introduction of a rotavirus vaccine is done by monitoring admissions for intussusception in a sentinel paediatric hospital and to compare data obtained
from medical records in the immediate pre-vaccine and post-vaccination period , ,  and . Although this methodology has a number of limitations, it may provide selleck chemical useful information that may otherwise not be available. Intussusception is a diagnosis that is well suited to sentinel site surveillance as the diagnosis and treatment of this condition requires radiological and surgical expertise that is generally focused at key paediatric hospitals. Failure to diagnose and treat intussusception is usually associated with bowel obstruction, bowel Libraries ischaemia, perforation and ultimately death. Therefore, hospital based surveillance may under represent the true incidence and outcome of intussusception,
particularly in resource
poor settings where access to paediatric diagnostic facilities and treatment is limited . In this study we aimed to assess the potential benefits and pitfalls of retrospective hospital based surveillance for intussusception in a sentinel paediatric hospital. We examined data collected retrospectively using hospital medical records during the period before and after introduction of a rotavirus vaccine into the National Immunisation Program in Australia. The Royal Children’s Hospital (RCH) is a major tertiary care paediatric hospital in Victoria providing for the care of the 70,000 annual birth cohort in Victoria, as well as specialist paediatric very care for children with complex conditions from elsewhere in Australia and the Asia-Pacific region. A retrospective chart review was conducted at the Royal Children’s Hospital over an 8-year period (July 1, 2001 to July 1, 2009). This period included 6 years prior to the introduction of Rotateq® into the National Immunisation Program and 2 years following this introduction. The medical records of all children aged <24 months admitted to the Royal Children’s Hospital over the study period with a discharge diagnosis of intussusception (ICD-10-CM K56.1) were obtained and systematically reviewed. A standardised data collection form was used to verify the diagnosis of intussusception and to collect additional descriptive data including clinical symptoms, signs, treatment and outcomes.